BioPharm International - September 2024

BioPharm International - September 2024

Issue link: https://www.e-digitaleditions.com/i/1526741

Contents of this Issue

Navigation

Page 31 of 31

Biologically Relevant Insights. Better Patient Outcomes. Sartorius accelerates the development of emerging therapies with innovative solutions for cell/protein analysis along with lab essentials and services to ensure complete confidence in your biotherapeutic discovery and development program. Find out why Sartorius is a leading partner in the research and production of: • Biosimilars • Cell and gene therapy • Immunotherapy • Monoclonal antibodies, ADCs, & bsAbs • Nanomedicine • Regenerative Medicine • RNA-based therapies including mRNA vaccines www.sartorius.com/biologics

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm International - September 2024 - BioPharm International - September 2024